4.4 Article

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

期刊

ARTHRITIS CARE & RESEARCH
卷 68, 期 1, 页码 1-25

出版社

WILEY
DOI: 10.1002/acr.22783

关键词

-

资金

  1. American College of Rheumatology
  2. Savient
  3. Allergan
  4. Regeneron
  5. Merz
  6. Iroko
  7. Bioiberica
  8. Takeda
  9. Dinora
  10. Horizon
  11. Abbott
  12. Amgen
  13. Bayer
  14. Bristol-Myers Squibb
  15. Lilly
  16. Merck
  17. Pfizer
  18. Roche/Genentech
  19. Ardea/AstraZeneca
  20. Crescendo
  21. AbbVie
  22. UCB
  23. Janssen
  24. Consortium of Rheumatology Researchers of North America (CORRONA) registry
  25. Actelion
  26. Cytori
  27. Gilead
  28. GlaxoSmithKline
  29. Novartis
  30. Roche
  31. Medac
  32. Antaes
  33. Medical Director of the North Mississippi Arthritis and Research Center
  34. Zimmer
  35. Mesoblast
  36. Genentech
  37. Ardea
  38. Sanofi
  39. Centocor
  40. Celgene
  41. Biogen
  42. Sanofi-Aventis
  43. Samumed
  44. Fidia
  45. Flexion
  46. McNeil Consumer Healthcare

向作者/读者索取更多资源

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to the recommendations within this guideline to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed and endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. ACR recommendations are not intended to dictate payment or insurance decisions. These recommendations cannot adequately convey all uncertainties and nuances of patient care. The ACR is an independent, professional, medical and scientific society that does not guarantee, warrant, or endorse any commercial product or service.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据